Amicus Therapeutics, Inc. (FOLD)
NASDAQ: FOLD · Real-Time Price · USD
14.41
-0.02 (-0.14%)
At close: Mar 27, 2026, 4:00 PM EDT
14.44
+0.03 (0.19%)
After-hours: Mar 27, 2026, 7:42 PM EDT

Amicus Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-27.11-56.11-151.58-236.57-250.46
Depreciation & Amortization
7.468.557.875.346.21
Stock-Based Compensation
87.4184.9186.0876.5157.84
Other Adjustments
5.0227.7136.5328.0212.86
Change in Receivables
-5.86-19.48-20.11-17.33-8.19
Changes in Inventories
-111.48-73.65-44.61-5.34-7.79
Changes in Accounts Payable
82.78-16.5249.2-6.387.43
Changes in Other Operating Activities
-5.0710.71-32.46-10.83-20.39
Operating Cash Flow
33.15-33.89-69.09-166.58-202.49
Capital Expenditures
-3.3-3.55-7.44-3.77-3.88
Sale of Property, Plant & Equipment
---3.41-
Purchases of Investments
-94.41-114.79-91.72-243.26-341.4
Proceeds from Sale of Investments
51.27117.78197.23335.93424.04
Investing Cash Flow
-46.43-0.5698.0692.3278.76
Long-Term Debt Issued
--387.36--
Long-Term Debt Repaid
-0.27-0.1-408.32-0.28-0.48
Net Long-Term Debt Issued (Repaid)
-0.27-0.1-20.96-0.28-0.48
Issuance of Common Stock
19.2127.24103.214.31229.21
Repurchase of Common Stock
-18.32-22.03-17.92-11.49-15.01
Net Common Stock Issued (Repurchased)
0.885.2285.29-7.18214.2
Other Financing Activities
---2.65--1.65
Financing Cash Flow
0.615.1261.68-7.46212.07
Effect of Exchange Rate Changes on Cash and Cash Equivalents
13.28-4.036.31-14.62-5.05
Net Cash Flow
0.6-33.3696.96-96.3483.29
Free Cash Flow
29.85-37.44-76.53-170.34-206.38
FCF Margin
4.71%-7.09%-19.16%-51.74%-67.55%
Free Cash Flow Per Share
0.10-0.12-0.26-0.59-0.76
Levered Free Cash Flow
-56.99-130.67-199.99-257.83-269.36
Unlevered Free Cash Flow
-4,684-25.93-105.42-228.3-232.47
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q